Skip to main content

Advertisement

Table 4 Proportion of patients with no detectable parasites grouped by malaria species and treatment arm

From: Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea

  P. falciparum P. vivax
AL DHA-PPQ P-value* AL DHA-PPQ P-value*
A) Fever clearance**
 Day 1 88.2 (60/68) 100 (64/64) 0.008 92.9 (13/14) 90.1 (10/11) 1.00
 Day 2 95.6 (65/68) 98.4 (63/64) 0.62 92.9 (13/14) 90.1 (10/11) 1.00
 Day 3 100 (68/68) 96.9 (62/64) 0.24 100 (14/14) 90.1 (10/11) 0.46
 Day 7 100 (68/68) 98.4 (63/64) 0.49 100 (14/14) 90.1 (10/11) 0.46
B) Parasite clearance
 Day 1 64.3 (83/129) 70 (101/145) 0.7 92.9 (26/28) 90.5 (38/42) 1.00
 Day 2 96.1 (124/129) 100 (142/142) 0.93 100 (28/28) 100 (42/42) 1.00
 Day 3 99.2 (128/129) 100 (143/143) 1.00 100 (28/28) 100 (42/42) 1.00
 Day 7 100 (129/129) 99 (141/142) 1.00 100 (28/28) 100 (42/42) 1.00
  1. Values are presented as % (n/N)
  2. * Fisher’s exact test
  3. ** Fever clearance was defined as axillary temperature < 37.3 °C after two consecutive events with ≥ 37.3 °C starting from day 0